Experience of surgical resection for hilar cholangiocarcinomas at a Japanese Single Cancer Institute

Hepato-Gastroenterology

Volumn 59, Issue 114, 2012, Pages 347-350

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Abo, Takafumi ^a   Machino, Ryusuke ^a   Takeshita, Hiroaki ^a   Nonaka, Takashi ^a   Hidaka, Shigekazu ^a   Tanaka, Kenji ^a   Kunizaki, Masaki ^a   Sawai, Terumitsu ^a   Yasutake, Toru ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Hepatectomy; Hilar bile duct carcinoma radical resection; Pancreatoduodenectomy

Indexed keywords

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEPATOJEJUNOSTOMY; HUMAN; HYPERBILIRUBINEMIA; LAPAROTOMY; LIVER ARTERY THROMBOSIS; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PANCREAS FISTULA; PERITONEUM METASTASIS; PHOTODYNAMIC THERAPY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL INFECTION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT SURGICAL PROCEDURES; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860596286     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge09718     Document Type: Article

References (32)

1. Ito F, Cho CS, Rikkers LF, Weber SM: Hilar cholangiocarcinoma: current management. Ann Surg 2009; 250:210-218.
2. Jonas S, Benckert C, Thelen A, et al.: Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 2008; 34:263-271.
3. Miyazaki M, Kato A, Ito H, et al.: Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 2007; 141:581-588. (Pubitemid 46616935)
4. Jarnagin WR, Fong Y, DeMatteo RP, et al.: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-517.
5. Yokoyama Y, Nagino M, Nishio H, et al.: Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolization. J Hepatobiliary Pancreat Surg 2007; 14:447-454. (Pubitemid 47517212)
6. Seyama Y, Makuuchi M: Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13:1505-1515. (Pubitemid 46672657)
7. Kondo S, Takada T, Miyazaki M, et al.: Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 2008; 15:41-54. (Pubitemid 351279840)
8. Baton O, Azoulay D, Adam DV, Castaing D: Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and long term outcomes. J Am Coll Surg 2007; 204:250-260. (Pubitemid 46124042)
9. Japanese Society of Biliary Surgery (JSBS): In: Nagakawa T ed. Classification of Biliary Tract Carcinoma. Tokyo: Kanehara & Co., Ltd., 2004:11-50.
10. Takasakil T, Kobayashi S, Suzuki S, et al.: Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980; 65:309-313. (Pubitemid 12155191)
11. Kubota K, Makuuchi M, Kusaka K, et al.: Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology 1997; 26:1176-1181. (Pubitemid 27509300)
12. Takayama T, Makuuchi M, Kubota K, et al.: Randomized comparison of ultrasonic vs. clamp transection of the liver. Arch Surg 2001; 136:922-928. (Pubitemid 32729553)
13. Nanashima A, Yamaguchi H, Shibasaki S, et al.: Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome. Hepatol Res 2004; 28:184-190. (Pubitemid 38351912)
14. Otani K, Chijiiwa K, Kai M, et al.: Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg 2008; 12:1033-1040.
15. Neuhaus P, Jonas S, Bechstein WO, et al.: Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230:808-818.
16. Nagino M, Kamiya J, Arai T, et al.: One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 2005; 137:148-155. (Pubitemid 40174421)
17. Tsalis K, Vasiliadis K, Kalpakidis V, et al.: A single-center experience in the management of Altemeier-Klatskin tumors. J Gastrointest Liver Dis 2007; 16:383-389.
18. Mansfield SD, Barakat O, Charnley RM, et al.: Pathology, treatment and outcome. World J Gastroenterol 2005; 11:7625-7630.
19. Mann CD, Neal CP, Pattenden CJ, et al.: Major resection of hepatic colorectal liver metastases in elderly patients - an aggressive approach is justified. Eur J Surg Oncol 2008; 34:428-432. (Pubitemid 351381285)
20. Parikh AA, Abdalla EK, Vauthey JN: Operative considerations in resection of hilar cholangiocarcinoma. HPB 2005; 7:254-258. (Pubitemid 43878470)
21. Nagino M, Nimura Y, Kamiya J, et al.: Right or left tri-segment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995; 117:677-681.
22. Nanashima A, Sumida Y, Abo T, et al.: Clinical significance of portal vein embolization before right hepatectomy. Hepatogastroenterol 2009; 56:773-777.
23. Nanashima A, Yamaguchi H, Shibasaki S, et al.: Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci 2006; 51:1190-1195. (Pubitemid 44341518)
24. Uesaka K, Nimura Y, Nagino M: Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996; 223:77-83. (Pubitemid 26030035)
25. Nagino M, Takada T, Miyazaki M, et al.: Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15:25-30. (Pubitemid 351279838)
26. Ferrero A, Lo Tesoriere R, Viganò L, et al.: Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg 2009; 33:318-25.
27. Nanashima A, Sumida Y, Abo T, et al.: Usefulness of measuring hepatic functional volume using Technetium-99m galactosyl serum albumin scintigraphy in bile duct carcinoma: report of two cases. J Hepatobiliary Pancreat Surg 2009; 16:386-393.
28. Nanashima A, Yamaguchi H, Shibasaki S, et al.: Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 2004; 39:1095-1101. (Pubitemid 39618794)
29. Murakami Y, Uemura K, Sudo T, et al.: Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 2009; 13:1470-1479.
30. Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C: Phase II study of S-1 in patients with advanced biliary tract cancer. Br j Cancer 2004; 91:1769-1774. (Pubitemid 39664963)
31. Watanabe T, Hirono H, Hasegawa K, Soga K, Shibasakl K, Yoneoka Y: Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa-advanced gastric cancer with metachronous peritonitis carcinomatosa and meningitis carcinomatosa. Intern Med 2009; 48:151-156.
32. Jonas S, Benckert C, Thelen A, et al.: Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 2008; 34:263-271.